IYIncilay Kalay Yildizhan

Incilay Kalay Yildizhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Incilay Kalay Yildizhan has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Characteristics, Management and Long‐Term Outcomes of 180 Patients With Early‐Stage Mycosis Fungoides at a Tertiary Centre—A 34‐Year Retrospective Study

    by Banu Ismail Mendi, Incilay Kalay Yıldızhan, Hatice Şanlı

    Background: Mycosis fungoides (MF) is the commonest form of primary cutaneous T‐cell lymphoma. Progression is slow, with frequent relapses. Data for predicting early‐stage MF progression and recurrence are inadequate.Methods: The clinical profile, treatment response, relapse, progression to advanced stage and final status of 180 patients diagnosed with early MF between January 1987 and September 2021 were investigated retrospectively.Results: Ninety‐four (52.2%) patients were female and 86 (47.8%) male. Stage at diagnosis was IA in 74 (41.1%) patients, IB in 72 (40%) and IIA in 34 (18.9%). Initial treatment was PUVA in 76 (42.2%) patients and NB–UVB in 59 (32.7%). Complete response occurred in 109 (60.5%) patients, and 73 (51.5%) patients experienced recurrence. Stage IA/IB at diagnosis, normal B‐2‐microglobulin levels and low CLIPI score were associated with complete response. Progression to advanced stage occurred in 27 (%15) patients. Age 60 and over at diagnosis, stage at diagnosis, pruritus, LDH, CLIPI score between 3 and 5, and folliculotropism in pathology were found to be negative prognostic factors in progression to advanced stage. Classical pathology, PUVA treatment and complete response to initial treatment were found to be positive prognostic factors. In multivariate analysis, LDH and complete responsiveness to initial treatment were independently associated with progression to advanced stage.Conclusion: Advanced age at diagnosis, a high CLIPI score and folliculotropism affect both progression to advanced stage and the final status of the disease. LDH level is a crucial indicator of progression to an advanced stage. Early diagnosis affects the treatment response, with a complete response to the initial treatment mitigating the risk of advanced‐stage progression.


  • Open Access

    Retrospective Evaluation of Clinical And Follow-Up Outcomes in Primary Cutaneous CD30+ Lymphoproliferative Disorders

    by Hatice Şanlı, Ahmet Taha Aydemir, İnCilay Kalay Yıldızhan, Aylin Heper, Işınsu Kuzu, Ayça Kırmızı, Ayşenur Botsalı, Bengü Nisa Akay

    This study evaluated the demographic data, clinical characteristics, treatment approaches, and treatment responses of 43 patients with primary cutaneous CD30+ lymphoproliferative disorders. Lymphomatoid papulosis (LyP) was characterized by predominantly papular (94.1%) and generalized (70.6%) lesions, while primary cutaneous anaplastic large-cell lymphoma (pcALCL) presented with tumoral (77.8%) and solitary (77.8%) lesions (p<0.001). Common treatments for LyP included methotrexate (response rate: 78.5%), topical corticosteroids (response rate: 83.3%), and phototherapy (response rate: 85.8%), but relapse rates were high. In pcALCL, complete remission was achieved with all treatments, with no relapses after brentuximab vedotin (BV). Secondary malignancies were noted in 20.6% of LyP cases. Both LyP and pcALCL had a 100% 5-year disease-specific survival rate, although two LyP patients (5.9%) died of secondary malignancies. In conclusion, LyP and pcALCL are both indolent lymphomas, with LyP being more prone to relapse. BV is effective for resistant pcALCL. LyP patients need long-term monitoring due to the risk of secondary malignancies.

  • Yenidoğanda Ender Bir Döküntülü Hastalık: Uyuz

    by Ergin Çiftçi, Belkıs Hatice İnceli, Döndü Nilay Penezoğlu, Hülya Akat, Elif Somuncu, Gül Arga, İnCilay Kalay Yıldızhan, Halil Özdemir

  • A Rare Exanthematous Disease in A Newborn: Scabies

    by Ergin Çiftçi, Belkıs Hatice İnceli, Döndü Nilay Penezoğlu, Hülya Akat, Elif Somuncu, Gül Arga, İnCilay Kalay Yıldızhan, Halil Özdemir

  • Open Access

    Contact Sensitivity of Turkish Children and Adolescents to European Baseline Series Allergens between 2013 and 2023

    by Incilay Kalay Yildizhan, Ayse Boyvat

    Introduction: Raising the numbers of patch testing in suspected children increases the rate of diagnosis of allergic contact dermatitis and the identification of clinically relevant allergens. Objective: The aim of this study to identify the most frequently observed allergens among Turkish children and adolescents patch tested in 2013-2023. Methods: The patch test results of 160 patients (age ≤18) were analyzed retrospectively. The frequency of contact allergens and distribution of positive results in terms of gender, age group (children and adolescents), and the presence of atopic dermatitis (AD) were identified. Results: Forty-nine patients (30.6%), 34 girls and 15 boys, exhibited positive patch test reactions to a minimum of one allergen, and contact sensitivity was statistically significant higher in girls (P=0.034). The 5 most frequent allergens were nickel sulfate (10.6%), methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) (8.1%), cobalt chloride (5.6%), p-phenylenediamine (PPD) (5%), and MI (3.5%). No significant association was observed between patch test positivity and age groups (p>.05). Nickel sulfate sensitivity was significantly higher in girls than boys (P=.043). A positive reaction was detected in 31.3% of patients with AD and in 33.7% of those without (P>.05) and a significant relationship was observed between contact sensitivity to fragrance allergens and AD (P=.046). Conclusion: Metals and preservatives represent the most frequent allergens in Turkish children and adolescents. Metal sensitivity is expected to decrease as legislation is enforced. Regulatory measures are now required to reduce MI and MCI/MI contact allergy in Turkey.


  • Open Access

    Isotretinoin Treatment Practices and Outcomes in Acne Patients During the COVID-10 Pandemic: A Single Center, Retrospective, Comparative Study

    by Mehmet Fatih Atak, Banu Ismail Mendi, Incilay Kalay Yildizhan, Hatice Erdi Sanli, Banu Farabi

    Introduction: The COVID-19 pandemic drastically changed the priorities in healthcare services; outpatient management of acne has changed during this period. Objectives: We aimed to investigate treatment practices, outcomes and identify modified follow-up schedules applied during the pandemic. Methods: The patients who were admitted to dermatology outpatient clinic between March 13 and July 13, 2020, were included. Patients who were admitted between March 13 and July 13, 2019, were served as controls for the study. For each patient, age, gender, treatment protocols, treatment intervals, compliance with the treatment, treatment modifications, and adverse events were recorded. Results: The total number of acne patients admitted to dermatology outpatient clinics during the pandemic period was 278 and consisted of 12.3% (278) of all admissions. Isotretinoin treatment was started in only 16 (5.8%) of the patients. The proportion of patients who were under follow-up was significantly higher during the pandemic period (P < 0.005). There was no difference between the pandemic period and the non-pandemic period in terms of starting isotretinoin treatment (P > 0.05). During pandemic period, 79% of the patients who used isotretinoin were followed-up every two or more months. Extended follow-up intervals showed no difference for detecting side effects (P > 0.05). Conclusions: Acne patients constitute an important part of dermatology outpatient clinics. During the pandemic period, the majority of acne patients came for follow-up. Extended follow-up periods were adopted by physicians and were found safe and effective in the current study. Thus, isotretinoin treatment seems efficacious and safe during pandemic period.


  • Complete remission with bexarotene gel in unilesional folliculotropic mycosis fungoides located on the scalp

    by Hatice Sanli, Incilay Kalay Yildizhan, Elif Demirci Saadet, Aylin Okcu Heper

    Click on the article title to read more.


  • A multicentre prospective analysis of the incidence of pemphigoid diseases in Turkey

    by Murat Durdu, Burçin Cansu Bozca, Servinaz Enli, Züleyha Yazıcı Özgen, Savaş Yaylı, Şebnem Aktan, Derya Mutlu, Ijlal Erturan, Havva Hilal Ayvaz Çelik, Mehmet Melikoğlu, et al.

    Background The differentiation between the pemphigoid diseases is essential for treatment and prognosis. In Turkey, data on the incidence of these diseases are insufficient. Our aim in this study is to determine the incidence, demographics and clinical characteristics associated with diseases of the pemphigoid group. Methods We prospectively analysed 295 patients with pemphigoid who visited dermatology clinics of tertiary referral hospitals in 12 different regions of Turkey within a year. The diagnosis was based on clinical, histopathological, direct immunofluorescence (DIF) and serological (multivariant enzyme-linked immunosorbent assay [ELISA], indirect immunofluorescence and mosaic-based BIOCHIP) examinations. Clinical and demographic findings, aetiological factors and concomitant diseases observed in the patients were recorded. Results A total of 295 (female/male ratio: 1.7/1) patients with pemphigoid were diagnosed in 1-year period. The overall incidence rate of pemphigoid diseases was found to be 3.55 cases per million-years. The ratio of pemphigoid group diseases to pemphigus group diseases was 1.6. The most common pemphigoid type was bullous pemphigoid (BP, 93.2%). The others were epidermolysis bullosa acquisita (3.1%), pemphigoid gestationis (2.4%), linear IgA disease (1%) and mucous membrane pemphigoid (0.3%). The most common (26.8%) possible trigger of the bullous pemphigoid was gliptin derivative drugs. The most common concomitant diseases with pemphigoid were cardiovascular (27.8%) and neurological diseases (23.7%). Conclusions This study showed that the increased frequency of bullous pemphigoid reversed the pemphigoid/pemphigus ratio in Turkey. Further studies are warranted regarding the reasons for this increase.


  • Open Access

    Rosai‐Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low‐dose thalidomide therapy

    by Incilay Kalay Yildizhan, Hatice Sanli, Bengü Nisa Akay, Handan Merve Erol, Işınsu Kuzu, Ayça Kırmızı, Güldane Cengiz Seval

    Click on the article title to read more.